The actress and singer-songwriter will serves as the brand ambassador for OptiLight, a new dry eye disease treatment.

Mr. Kuruganti’s role on the board will include outreach to many in the software and tech industries, as well as offering expert advice to the organization as EyeCare4Kids expands services both on a domestic and international level.

Listen to this week's episode!

The removal of preservatives may be beneficial for the ocular health of glaucoma patients

Canadian researchers have found that rapid antigen tests to detect the SARS-CoV-2 virus are associated with a very low rate of false positive results.

The FDA announced approval of the first generic version of Restasis (cyclosporine ophthalmic emulsion) 0.05% eye drops Thursday.

Diagnosing COVID-19 just got faster with a test that claims to provide rapid virus detection markedly faster than reverse-transcriptase polymerase chain reaction (RT-PCR) testing.

Fashion icon to share how he stayed motivated to innovate despite challenging beginnings

The optical technology company announced two updates to their product line.

Investigators report that maintenance hemodialysis does not seem to impact the effectiveness of vaccines against the COVID-19 virus in most study patients.

Black EyeCare Perspective is connecting communities with Black eye care professionals, optometrists and ophthalmologists

Faricimab is now the first and only FDA-approved drug to target two distinct pathways known to cause retinal disease that may lead to vision loss.

Ahead of World Neglected Tropical Diseases (NTD) Day on Jan. 30, Alemayehu Sisay, MD, MPH, country director for Orbis Ethiopia, discusses efforts and progress the organization has made in treating patients with NTDs and how to get involved in recognizing World NTD Day.

Research also highlights the top factors that lead to care, which can be used to improve parents' uptake of sight-saving surgery for their children.

The annual national conference in February will offer 3 intensive days of business management curricula, COPE-approved clinical education, staff training and high-profile guest speakers.

Significant differences were found in the pupillary diameters between when the virus was active and 3 months later, Turkish investigators report.

Manufacturing of the omicron-specific vaccine has already begun.

Positive one-year results of Genentech’s phase III trials analyzing faricimab for treatment of wet AMD and DME were released today.

Saudi Arabian investigators have determined that Vitamin D levels are not protective against the severity or the outcomes of COVID-19 infections.